EHA 2020 | Novel insights into genomic classification and prognosis in AML

Name: Novel insights into genomic classification and prognosis in AML
Uploaded: 2020-06-15T00:00:00Z
Duration: 1 min 51 s
Description: Lars Bullinger, MD, of Charité University of Medicine, Berlin, Germany, discusses novel insights into genomic classification and prognosis of acute myeloid leukemia (AML) based on a pan-European public-private partnership, The Harmony Alliance. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Lars Bullinger • 15 Jun 2020

EHA 2020

Acute Myeloid Leukemia Leukemia

Lars Bullinger, MD, of Charité University of Medicine, Berlin, Germany, discusses novel insights into genomic classification and prognosis of acute myeloid leukemia (AML) based on a pan-European public-private partnership, The Harmony Alliance. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).